DK0414475T3 - Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier - Google Patents
Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinierInfo
- Publication number
- DK0414475T3 DK0414475T3 DK90309120.5T DK90309120T DK0414475T3 DK 0414475 T3 DK0414475 T3 DK 0414475T3 DK 90309120 T DK90309120 T DK 90309120T DK 0414475 T3 DK0414475 T3 DK 0414475T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- cell lines
- lymphocyte cell
- culturing hcv
- hcv
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 210000003719 b-lymphocyte Anatomy 0.000 title 1
- 238000012258 culturing Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
- Details Of Audible-Bandwidth Transducers (AREA)
- Telephone Function (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39866789A | 1989-08-25 | 1989-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0414475T3 true DK0414475T3 (da) | 1998-02-09 |
Family
ID=23576300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90309120.5T DK0414475T3 (da) | 1989-08-25 | 1990-08-21 | Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0414475B1 (de) |
JP (3) | JPH05502156A (de) |
AT (1) | ATE161041T1 (de) |
AU (1) | AU655156B2 (de) |
CA (1) | CA2064705C (de) |
DE (1) | DE69031791T2 (de) |
DK (1) | DK0414475T3 (de) |
ES (1) | ES2110411T3 (de) |
GR (1) | GR3026114T3 (de) |
IE (1) | IE903097A1 (de) |
PT (1) | PT95093B (de) |
WO (1) | WO1991002820A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
DK298190A (da) | 1989-12-18 | 1991-06-19 | Wellcome Found | Viralt middel |
CA2079677A1 (en) * | 1990-04-03 | 1991-10-04 | Kenneth H. Burk | Purified hcv and hcv proteins and peptides |
WO1991015596A1 (en) * | 1990-04-04 | 1991-10-17 | Protos, Inc. | Hepatitis c virus protease inhibitors |
WO1991015516A2 (en) * | 1990-04-06 | 1991-10-17 | Genelabs Incorporated | Hepatitis c virus epitopes |
US5747339A (en) | 1990-06-25 | 1998-05-05 | Research Foundation For Microbial Diseases Of Osaka | Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
EP0516270A3 (en) * | 1991-04-10 | 1993-06-23 | Immuno Japan Inc. | Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides |
US5428145A (en) * | 1991-08-09 | 1995-06-27 | Immuno Japan, Inc. | Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems |
AU671967B2 (en) | 1991-11-21 | 1996-09-19 | Common Services Agency | Hepatitis-C virus testing |
US5552310A (en) * | 1992-06-12 | 1996-09-03 | Hiroshi Yoshikura | Replication of hepatitis C virus genome and identification of virus having high infectivity |
AU6943994A (en) * | 1993-05-04 | 1994-11-21 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Hepatitis c virus cell propagation and related methods |
US5840565A (en) | 1995-08-22 | 1998-11-24 | The Regents Of The University Of California | Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
US6127116A (en) | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US5851758A (en) * | 1995-10-25 | 1998-12-22 | Childrens Research Institute | Cytopathic replication of hepatitis C virus in a new cell line |
US6242187B1 (en) | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
CN1263867C (zh) * | 1996-01-29 | 2006-07-12 | 病毒科学公司 | 用于确定抗病毒药物敏感性和抗性和筛选抗病毒药物的组合物和方法 |
CA2269097C (en) | 1996-11-08 | 2007-01-09 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Synthesis and purification of hepatitis c virus-like particles |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
AT407256B (de) * | 1998-06-24 | 2001-02-26 | Immuno Ag | Hepatitis c-virus positive endometriale zelllinie |
ATE517184T1 (de) | 2000-08-17 | 2011-08-15 | Tripep Ab | Hcv ns3/4a kodierende nukleinsäure |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
EP1888751A2 (de) | 2005-05-25 | 2008-02-20 | Tripep Ab | Nichtstrukturelles ns3/4a-fusionsgen des hepatitis-c-virus |
US20090214593A1 (en) | 2007-08-16 | 2009-08-27 | Tripep Ab | Immunogen platform |
EP2185195A2 (de) | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen-plattform |
GB201119011D0 (en) * | 2011-11-03 | 2011-12-14 | Queen Mary Innovation Ltd | Method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464474A (en) * | 1980-07-09 | 1984-08-07 | Connaught Laboratories Limited | Non-A, non-B hepatitis assay and vaccine |
GB2108527B (en) * | 1981-02-11 | 1984-10-24 | Connaught Lab | Non-a non-b hepatitis virus |
EP0261233A4 (de) * | 1986-04-01 | 1988-08-29 | Genelabs Inc | Immortalisierte virus-spezifische gewebezellen. |
WO1989004669A1 (en) * | 1987-11-18 | 1989-06-01 | Chiron Corporation | Nanbv diagnostics and vaccines |
-
1990
- 1990-08-21 ES ES90309120T patent/ES2110411T3/es not_active Expired - Lifetime
- 1990-08-21 AT AT90309120T patent/ATE161041T1/de not_active IP Right Cessation
- 1990-08-21 EP EP90309120A patent/EP0414475B1/de not_active Expired - Lifetime
- 1990-08-21 DK DK90309120.5T patent/DK0414475T3/da active
- 1990-08-21 DE DE69031791T patent/DE69031791T2/de not_active Expired - Lifetime
- 1990-08-22 CA CA002064705A patent/CA2064705C/en not_active Expired - Lifetime
- 1990-08-22 JP JP2512531A patent/JPH05502156A/ja not_active Withdrawn
- 1990-08-22 WO PCT/US1990/004766 patent/WO1991002820A1/en active Application Filing
- 1990-08-22 AU AU63449/90A patent/AU655156B2/en not_active Expired
- 1990-08-24 PT PT95093A patent/PT95093B/pt not_active IP Right Cessation
- 1990-08-24 IE IE309790A patent/IE903097A1/en not_active IP Right Cessation
-
1998
- 1998-02-12 GR GR980400286T patent/GR3026114T3/el unknown
-
2001
- 2001-03-15 JP JP2001075114A patent/JP2001314192A/ja not_active Withdrawn
-
2003
- 2003-06-24 JP JP2003180211A patent/JP2004049235A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004049235A (ja) | 2004-02-19 |
ES2110411T3 (es) | 1998-02-16 |
DE69031791D1 (de) | 1998-01-22 |
DE69031791T2 (de) | 1998-04-02 |
EP0414475A1 (de) | 1991-02-27 |
AU6344990A (en) | 1991-04-03 |
WO1991002820A1 (en) | 1991-03-07 |
PT95093B (pt) | 1997-11-28 |
PT95093A (pt) | 1991-05-22 |
JP2001314192A (ja) | 2001-11-13 |
JPH05502156A (ja) | 1993-04-22 |
CA2064705A1 (en) | 1991-02-26 |
ATE161041T1 (de) | 1997-12-15 |
EP0414475B1 (de) | 1997-12-10 |
CA2064705C (en) | 1999-04-06 |
GR3026114T3 (en) | 1998-05-29 |
IE903097A1 (en) | 1991-02-27 |
AU655156B2 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0414475T3 (da) | Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier | |
YU45871B (sh) | Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima | |
DK0451611T3 (da) | Human hæmatopoietisk stamcelle | |
DK0891420T4 (da) | Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus | |
ATE482267T1 (de) | Tierzellen und verfahren für die replikation von influenza viren | |
DE59209058D1 (de) | Kultivierung von Vero-Zellen | |
DE69534595D1 (de) | Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür | |
DK372780A (da) | Fremgangsmaade til propagering af humant hepatitis a virus | |
ATE530657T1 (de) | Verfahren zur herstellung von zellinien mit latentem immunschwächevirus | |
ES8104405A1 (es) | Procedimiento para preparar una vacuna de virus de gripe | |
DK0658626T3 (da) | Fremgangsmåder til produktion af protein C | |
DK0651788T3 (da) | Fremgangsmåde til dyrkning af en celletype i en cokulturfremgangsmåde med leverceller | |
DK439086D0 (da) | Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener | |
DK713188A (da) | Fremgangsmaade til fremstilling af pregneno-oxazoliner | |
DK0485504T3 (da) | Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning | |
DK628188A (da) | Protein og fremgangsmaade til fremstilling deraf | |
FR2585722B1 (fr) | Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees | |
DK204586A (da) | Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet | |
DK107493A (da) | Vektor for udtrykkelse i gaer, bestaaende af et fremmed dna-segment og en fremgangsmaade til syntese af fremmede proteiner ved hjaelp af en saadan vektor |